Understanding immunotherapy and its management
Open Access
- 12 January 2021
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Immunotherapy and Cancer Research
- Vol. 7 (1), 001-007
- https://doi.org/10.17352/2455-8591.000030
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapyAutoimmunity Reviews, 2018
- Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)Oncology Letters, 2018
- Cancer immunotherapy: a brief review of the history, possibilities, and challenges aheadJournal of Cancer Metastasis and Treatment, 2017
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical OutcomeFrontiers in Pharmacology, 2017
- Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyJournal of Hematology & Oncology, 2016
- Evolving role of immunotherapy in the treatment of refractory wartsIndian Dermatology Online Journal, 2016
- Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primerJournal for ImmunoTherapy of Cancer, 2014
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Evaluation of the clinical and allergen specific serum immunoglobulin E responses to oral challenge with cornstarch, corn, soy and a soy hydrolysate diet in dogs with spontaneous food allergyVeterinary Dermatology, 2003
- Specific Allergen Immunotherapy for Allergic Rhinitis and AsthmaPediatric Annals, 2000